"Located in Hong Kong, the Center is the first independent clinical trials clinic in the private market. With a proven track record in designing and conducting clinical trials in the region, we partner with pharmaceutical, healthtech, medtech and biotech companies with study design tailored solutions and conduct of clinical trials to bring the latest innovations to market. The Center has a depth of expertise in the fields of aging, osteoarthritis, diabetes mellitus, and Alzheimer's disease, woman’s health and other degenerative disease."

During the past decade, CCBR Hong Kong conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCBR Hong Kong" #1 collaborator was "Novartis" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CCBR Hong Kong" are "Osteoarthritis" (2 trials) and "Osteoporosis" (1 trials). Many other conditions were trialed in "CCBR Hong Kong" in a lesser frequency.

Most popular intervention types in "CCBR Hong Kong" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "SMC021 Placebo" (2 trials), "Oral Salmon Calcitonin" (1 trials), "Oral Salmon Calcitonin (Placebo)" (1 trials), "SMC021 Oral Calcitonin" (1 trials) and "SMC021 Oral calcitonin" (1 trials). Other intervention names were less common.

The vast majority of trials in "CCBR Hong Kong" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CCBR Hong Kong". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CCBR Hong Kong, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CCBR Hong Kong, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".